Price T Rowe Associates Inc TONIX PHARMACEUTICALS HLDG C Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
N/A
-43,337 Closed
0 $0
Q1 2022

May 16, 2022
BUY
N/A
15,071 Added 53.32%
43,337 $10,000
Q4 2021

Feb 14, 2022
BUY
N/A
609 Added 2.2%
28,266 $10,000
Q3 2021

Nov 15, 2021
BUY
N/A
1,400 Added 5.33%
27,657 $17,000
Q2 2021

Aug 16, 2021
BUY
N/A
26,257 New
26,257 $29,000
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email